China SXT Pharmaceuticals (SXTC) Assets: 2019-2025
- China SXT Pharmaceuticals' Assets fell 14.98% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.4 million, marking a year-over-year decrease of 14.98%. This contributed to the annual value of $21.7 million for FY2025, which is 6.33% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Assets of $26.4 million as of Q3 2025, which was up 21.65% from $21.7 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Assets ranged from a high of $34.5 million in Q1 2021 and a low of $14.6 million during Q3 2023.
- Its 3-year average for Assets is $24.4 million, with a median of $24.7 million in 2024.
- Per our database at Business Quant, China SXT Pharmaceuticals' Assets slumped by 34.23% in 2023 and then soared by 112.49% in 2024.
- China SXT Pharmaceuticals' Assets (Quarterly) stood at $22.7 million in 2021, then decreased by 2.16% to $22.2 million in 2022, then tumbled by 34.23% to $14.6 million in 2023, then soared by 112.49% to $31.0 million in 2024, then dropped by 14.98% to $26.4 million in 2025.
- Its last three reported values are $26.4 million in Q3 2025, $21.7 million for Q1 2025, and $31.0 million during Q3 2024.
